Instructions for Dexalgin 25 (Dexketoprofen) 10 pills
English product name
Dexalgin® 25
Release form
25 mg of film wrap
Description Dexketoprofen:
The tablets are covered with a film shell of white color, round, double-convex, with a risk on both sides.
1 tab.
dexamoprofen trometamol 36.9 mg,
dexamoprofen content 25 mg
Auxiliary substances: cellulose microcrystalline - 141.2 mg, cornstarch - 49.6 mg, sodium carboxymethyl starch (type A) - 27.1 mg, glyceryl palmitostearate - 5.2 mg.
Film sheath composition: hypromellose - 1.34 mg, titanium dioxide (E171) - 0.36 mg, macrogol 6000 - 0.6 mg, propylene glycol - 0.42 mg.
ATC codes Dexketoprofen
M01AE17 Dexketoprofen
Clinical-pharmacological groups / Group affiliation
NAPS
Active substance Dexalgin
decketoprofen
Pharmacotherapy group:
NSAIDs
Pharmacological effect:
NAPS. It has anti-inflammatory, analgesic and antipyretic effects. The mechanism of action is based on the suppression of prostaglandin synthesis due to COX suppression.
Analgesic Dexalgin effect occurs 30 minutes after reception, duration of action four - six
Testimony Dexalgin:
- To receive inside:
- mild to moderate pain syndrome in the following diseases and conditions:
- acute and chronic inflammatory diseases of the musculoskeletal system (rheumatoid arthritis,
- spondyloarthritis, arthrosis, osteochondrosis);
- Dysmenorrhea;
- toothache.
- For parenteral administration:
- Pain management of various types of pain (including post-operative pain,
- bone metastasis pain,
- post-traumatic pain,
- kidney colic pain,
- algodismenorrhea,
- scialgia,
- radiculitis,
- neuralgia, toothache);
- symptomatic treatment of acute and chronic inflammatory,
- inflammatory, degenerative and metabolic diseases of the musculoskeletal system (including rheumatoid arthritis, osteoarthrosis, spondyloarthritis: ankylosing spondylitis, reactive arthritis,
- psoriatic arthritis).
Method of use, course and dosage Dexalgin:
For ingestion, the average single dose is 12.5 mg - one to six times daily.
Every 4-6 hours as required or 25 mg 1-3 times/day every 8 hours. The maximum daily dose is 75 mg.
The duration of the use of the preparation is not more than three to five days.
For parenteral administration (v/m or v/v), the recommended dose for adults is 50 mg every eight to 12 hours.
For patients with liver or kidney dysfunction, elderly patients the initial dose is not more than 50 mg/day.
Application in elderly patients
Care should be taken when administering the drug Dexketoprofen to elderly patients. For the elderly, the initial dose is not more than 50 mg/day.
Use in children
The preparation is contraindicated for use in children and adolescents under the age of 18
- Nosology Dexalgin (ICD codes)
- K08.8
- Other refined changes of teeth and their support apparatus (including toothache)
- M02
- Reactive arthropathy
- M05
- Seropositive rheumatoid arthritis
- M07
- Psoriatic and enteropathic arthropathy
- M13.9
- Arthritis unspecified
- M15
- Polyarthrosis
- M19.9
- Arthrosis unspecified
- M25.5
- Joint pain
- M42
- Spinal osteochondrosis
- M45
- Ankylosing spondylitis
- M47
- Spondylosis
- M54.1
- Radikulopathy
- M54.3
- Ishias
- M54.4
- Lumbago with Sciatica
- M79.2
- Neuralgia and Neuritis Unspecified
- N23
- Renal colic unspecified
- N94.4
- Primary dysmenorrhea
- N94.5
- Secondary dysmenorrhea
- R52.0
- Acute pain
- R52.2
- Other persistent pain (chronic) Dexketoprofen
- T14.3
- Dislocation, stretching and overtension of the capsule-bonding apparatus of the unspecified body region joint
